Literature DB >> 16867216

Loss of adhesion in the circulation converts amelanotic metastatic melanoma cells to melanotic by inhibition of AKT.

Weihua Zhang1, Rachel Tsan, Do-Hyun Nam, Weixin Lu, Isaiah J Fidler.   

Abstract

Direct injection of murine K-1735 melanoma cells into the subcutis, lung, or brain of syngeneic mice produces amelanotic tumors, whereas intravenous injection into the lateral tail vein or internal carotid artery produces both amelanotic and melanotic foci in the lung and the brain respectively. We hypothesized that loss of adhesion in the circulation may contribute to the melanogenic phenotypes of cells. To test this, we used enforced suspension culture of K-1735 cells by consistent rotating culture of K-1735 cells. We found that the expression of the microphthalmia transcription factor (MITF) and melanin-stimulating hormone receptor (MSHR) were upregulated in cells growing in suspension and were accompanied by inhibitions of AKT and ERK, which were reversed in cells upon regrowth as an adherent monolayer. Inhibition of the AKT pathway was responsible for MITF induction by suspension culture. Stable expression of constitutively active AKT significantly repressed the melanogenesis of K-1735 cells injected via circulation. An amelanotic clone of K-1735 cells was resistant to suspension culture-induced MITF, although the inhibition of AKT pathway was intact. Collectively, these data suggest that the inhibition of AKT pathway due to loss of adhesion within the circulation renders a subpopulation of K-1735 cells to produce melanin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867216      PMCID: PMC1601939          DOI: 10.1593/neo.05655

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  33 in total

1.  Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma.

Authors:  C J Bruns; C C Solorzano; M T Harbison; S Ozawa; R Tsan; D Fan; J Abbruzzese; P Traxler; E Buchdunger; R Radinsky; I J Fidler
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

2.  The distribution of secondary growths in cancer of the breast. 1889.

Authors:  S Paget
Journal:  Cancer Metastasis Rev       Date:  1989-08       Impact factor: 9.264

3.  Global gene expression profiling of circulating tumor cells.

Authors:  Denis A Smirnov; Daniel R Zweitzig; Bradley W Foulk; M Craig Miller; Gerald V Doyle; Kenneth J Pienta; Neal J Meropol; Louis M Weiner; Steven J Cohen; Jose G Moreno; Mark C Connelly; Leon W M M Terstappen; S Mark O'Hara
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

4.  Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines.

Authors:  I J Fidler; G L Nicolson
Journal:  J Natl Cancer Inst       Date:  1976-11       Impact factor: 13.506

5.  Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9.

Authors:  W Xu; L Gong; M M Haddad; O Bischof; J Campisi; E T Yeh; E E Medrano
Journal:  Exp Cell Res       Date:  2000-03-15       Impact factor: 3.905

6.  Site-specific metastasis of mouse melanomas and a fibrosarcoma in the brain or meninges of syngeneic animals.

Authors:  G Schackert; I J Fidler
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

7.  Biological diversity in metastatic neoplasms: origins and implications.

Authors:  I J Fidler; I R Hart
Journal:  Science       Date:  1982-09-10       Impact factor: 47.728

8.  Positive and negative elements regulate a melanocyte-specific promoter.

Authors:  P Lowings; U Yavuzer; C R Goding
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

9.  Influence of organ microenvironment on pigmentation of a metastatic murine melanoma.

Authors:  J E Price; D Tarin; I J Fidler
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

10.  Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin.

Authors:  I J Fidler; E Gruys; M A Cifone; Z Barnes; C Bucana
Journal:  J Natl Cancer Inst       Date:  1981-10       Impact factor: 13.506

View more
  6 in total

1.  p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors.

Authors:  Stuart J Gallagher; John F Thompson; James Indsto; Lyndee L Scurr; Margaret Lett; Bo-Fu Gao; Ruth Dunleavey; Graham J Mann; Richard F Kefford; Helen Rizos
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

2.  Skeletal muscle phenotypically converts and selectively inhibits metastatic cells in mice.

Authors:  Ara Parlakian; Iman Gomaa; Sounkary Solly; Ludovic Arandel; Alka Mahale; Gustav Born; Giovanna Marazzi; David Sassoon
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

3.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

4.  Inhibitory effects of Taraxacum mongolicum with phreatic water on melanin synthesis.

Authors:  Moon-Hee Jang; Taek-Won Ahn
Journal:  Integr Med Res       Date:  2014-08-30

5.  Expression of human papilloma virus type 16 E5 protein in amelanotic melanoma cells regulates endo-cellular pH and restores tyrosinase activity.

Authors:  Fabio Di Domenico; Cesira Foppoli; Carla Blarzino; Marzia Perluigi; Francesca Paolini; Salvatrice Morici; Raffaella Coccia; Chiara Cini; Federico De Marco
Journal:  J Exp Clin Cancer Res       Date:  2009-01-08

6.  Reprogramming human A375 amelanotic melanoma cells by catalase overexpression: Reversion or promotion of malignancy by inducing melanogenesis or metastasis.

Authors:  Candelaria Bracalente; Noelia Salguero; Cintia Notcovich; Carolina B Müller; Leonardo L da Motta; Fabio Klamt; Irene L Ibañez; Hebe Durán
Journal:  Oncotarget       Date:  2016-07-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.